Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
Journal
Metabolism: clinical and experimental
Journal Volume
131
Date Issued
2022
Author(s)
Nguyen, Nam Nhat
Ho, Dung Si
Nguyen, Hung Song
Ho, Dang Khanh Ngan
Lin, Chia-Yuan
Chiu, Hsiao-Yean
Chen, Yang-Ching
Abstract
Diabetes is an independent predictor of poor outcomes in patients with COVID-19. We compared the effects of the preadmission use of antidiabetic medications on the in-hospital mortality of patients with COVID-19 having type 2 diabetes.
Subjects
Antidiabetic medication; COVID-19; Type 2 diabetes mellitus
Type
journal article